These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 12164028)

  • 1. Management of men with a first episode of acute urinary retention due to benign prostatic enlargement.
    Abeygunasekera AM; de Silva S; Gurusingha A; Wijeratne S
    Ceylon Med J; 2001 Dec; 46(4):124-5. PubMed ID: 12164028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Tamsulosin in the treatment of benign prostatic hyperplasia patients with acute urinary retention].
    Hua LX; Wu HF; Sui YG; Chen SG; Xu ZQ; Zhang W; Qian LX
    Zhonghua Nan Ke Xue; 2003 Oct; 9(7):510-1. PubMed ID: 14628599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravesical prostatic protrusion is better than prostate volume in predicting the outcome of trial without catheter in white men presenting with acute urinary retention: a prospective clinical study.
    Mariappan P; Brown DJ; McNeill AS
    J Urol; 2007 Aug; 178(2):573-7; discussion 577. PubMed ID: 17570437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term outcome of patients with a successful trial without catheter, after treatment with an alpha-adrenergic receptor blocker for acute urinary retention caused by benign prostatic hyperplasia.
    Lo KL; Chan MC; Wong A; Hou SM; Ng CF
    Int Urol Nephrol; 2010 Mar; 42(1):7-12. PubMed ID: 19449121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Response to daily 10 mg alfuzosin predicts acute urinary retention and benign prostatic hyperplasia related surgery in men with lower urinary tract symptoms.
    Emberton M; Lukacs B; Matzkin H; Alcaraz A; Elhilali M; Vallancien G
    J Urol; 2006 Sep; 176(3):1051-6. PubMed ID: 16890690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of successful trial without catheter following acute urinary retention in benign prostatic enlargement: A single centre, multivariate analysis.
    Bansal A; Arora A
    Neurourol Urodyn; 2017 Sep; 36(7):1757-1762. PubMed ID: 28101889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical outcomes after combined therapy with dutasteride in patients with unsuccessful trial without catheter after treatment with an alpha1-adrenergic receptor blocker monotherapy for acute urinary retention caused by prostatic hyperplasia].
    Inahara M; Sugiura M; Kaga K; Hou K; Araki K; Masuda H; Kojima S; Naya Y
    Nihon Hinyokika Gakkai Zasshi; 2014 Oct; 105(4):190-5. PubMed ID: 25757349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. alpha-receptor blockade for benign prostatic hyperplasia: uses and problems in a developing country.
    Ogbonna BC; Okeahialam BN; Ramyil VM
    Br J Urol; 1997 Jan; 79(1):32-5. PubMed ID: 9043492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The management of acute urinary retention in France: a cross-sectional survey in 2618 men with benign prostatic hyperplasia.
    Desgrandchamps F; De La Taille A; Doublet JD;
    BJU Int; 2006 Apr; 97(4):727-33. PubMed ID: 16536763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sustained-release alfuzosin and trial without catheter after acute urinary retention: a prospective, placebo-controlled.
    McNeill SA; Daruwala PD; Mitchell ID; Shearer MG; Hargreave TB
    BJU Int; 1999 Oct; 84(6):622-7. PubMed ID: 10510105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The mechanism of action of the alpha-adrenoblocker prazosin on bladder function in patients with benign prostatic hyperplasia].
    Loran OB; Vishnevskiĭ AE
    Urol Nefrol (Mosk); 1997; (4):19-22. PubMed ID: 9381614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Results of treatment with tamsulosin in men with acute urinary retention.
    Kim HL; Kim JC; Benson DA; Bales GT; Gerber GS
    Tech Urol; 2001 Dec; 7(4):256-60. PubMed ID: 11763483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of doxazosin in the treatment of acute urinary retention due to benign prostate hyperplasia.
    Prieto L; Romero J; López C; Ortiz M; Pacheco JJ
    Urol Int; 2008; 81(1):66-71. PubMed ID: 18645274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomised, placebo controlled, double blind study of alfuzosin SR in patients undergoing trial without catheter following acute urinary retention.
    Shah T; Palit V; Biyani S; Elmasry Y; Puri R; Flannigan GM
    Eur Urol; 2002 Oct; 42(4):329-32; discussion 332. PubMed ID: 12361896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostate size influences the outcome after presenting with acute urinary retention.
    McNeill AS; Rizvi S; Byrne DJ
    BJU Int; 2004 Sep; 94(4):559-62. PubMed ID: 15329112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of high-energy transurethral microwave thermotherapy in alleviating medically refractory urinary retention due to benign prostatic hyperplasia.
    Kellner DS; Armenakas NA; Brodherson M; Heyman J; Fracchia JA
    Urology; 2004 Oct; 64(4):703-6. PubMed ID: 15491705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of the addition of tadalafil to tamsulosin in the treatment of acute urinary retention in patients with benign prostatic hyperplasia: A randomized clinical trial.
    Baghani Aval H; Ameli Z; Ameli M
    Urologia; 2018 May; 85(2):51-54. PubMed ID: 30043714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Reten-World survey of the management of acute urinary retention: preliminary results.
    Emberton M; Fitzpatrick JM
    BJU Int; 2008 Mar; 101 Suppl 3():27-32. PubMed ID: 18307683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tamsulosin in the management of patients in acute urinary retention from benign prostatic hyperplasia.
    Lucas MG; Stephenson TP; Nargund V
    BJU Int; 2005 Feb; 95(3):354-7. PubMed ID: 15679793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intraprostatic botulinum toxin type a injection in patients unfit for surgery presenting with refractory urinary retention and benign prostatic enlargement. Effect on prostate volume and micturition resumption.
    Silva J; Silva C; Saraiva L; Silva A; Pinto R; Dinis P; Cruz F
    Eur Urol; 2008 Jan; 53(1):153-9. PubMed ID: 17825981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.